Skip to Main content Skip to Navigation
Journal articles

Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis

Abstract : The product of the Rv2276 gene of Mycobacterium tuberculosis is a cytochrome P450 (P450 MT2, CYP121) which has been shown to bind tightly to a range of azole-based antifungal drugs (e.g. miconazole, clotrimazole). These drugs are potent inhibitors of mycobacterial growth, suggesting that P450 MT2 (CYP121) may be a potential drug target. The enzyme has been overexpressed in Escherichia coli and crystallized by the hanging-drop method. Crystals of P450 MT2 (CYP121) belong to the hexagonal space group P6(1)22 or P6(5)22, with unit-cell parameters a = b = 78.3, c = 265.6 A. Native data have been collected to 1.6 A resolution and Hg-derivative data to 2.5 A resolution using a synchrotron-radiation source.
Keywords : cytochrome P450
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03144700
Contributor : Marie de Tarragon <>
Submitted on : Wednesday, February 17, 2021 - 6:21:11 PM
Last modification on : Wednesday, March 24, 2021 - 3:21:30 AM

Links full text

Identifiers

Collections

Citation

Christopher Mowat, David Leys, Kirsty Mclean, Stuart Rivers, Alison Richmond, et al.. Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis. Acta Crystallographica Section D: Biological Crystallography, International Union of Crystallography, 2002, 58 (4), pp.704-705. ⟨10.1107/s0907444902002676⟩. ⟨pasteur-03144700⟩

Share

Metrics

Record views

14